Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Return on Equity (2016)

Historic Return on Equity for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to 3.2%.

  • Tenax Therapeutics' Return on Equity fell 27600.0% to 3.2% in Q3 2017 from the same period last year, while for Sep 2017 it was 3.2%, marking a year-over-year decrease of 27600.0%. This contributed to the annual value of 1.02% for FY2016, which is N/A changed from last year.
  • As of Q3 2017, Tenax Therapeutics' Return on Equity stood at 3.2%, which was down 27600.0% from 3.05% recorded in Q2 2017.
  • Tenax Therapeutics' Return on Equity's 5-year high stood at 74.34% during Q2 2013, with a 5-year trough of 121.83% in Q1 2013.
  • Its 3-year average for Return on Equity is 8.33%, with a median of 2.78% in 2017.
  • Examining YoY changes over the last 5 years, Tenax Therapeutics' Return on Equity showed a top increase of 2313700bps in 2013 and a maximum decrease of -1262500bps in 2013.
  • Tenax Therapeutics' Return on Equity (Quarter) stood at 74.34% in 2013, then plummeted by -102bps to 1.36% in 2016, then plummeted by -135bps to 3.2% in 2017.
  • Its Return on Equity was 3.2% in Q3 2017, compared to 3.05% in Q2 2017 and 2.78% in Q1 2017.